Lupus nephritis

Related records

Broader conditions (10)

• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Glomerular disorder
• Glomerulonephritis
• Human disease
• Inflammatory disease
• Kidney disorder
• Nephritis
• Urinary system disorder

Trials (326)

• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
• A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
• A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
• A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
• A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
• A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
• A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
• A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
• A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
• A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
• A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
• A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
• A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis
• A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
• A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
• A Study of ANX009 in Adult Participants With Lupus Nephritis
• A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Approved drugs (2)

• Belimumab
• Voclosporin

Drugs in development (55)

• Abatacept Phase 3
• Abetimus sodium Phase 3
• Acetaminophen Phase 3
• Anifrolumab Phase 3
• Atacicept Phase 3
• Azathioprine Phase 3
• BIIB-023 Phase 2
• Curcumin Phase 2
• Cyclophosphamide Phase 3
• Cyclosporine Phase 3
• Dapagliflozin Phase 1
• Daratumumab Phase 2
• Daxdilimab Phase 2
• Dazodalibep Phase 2
• Deucravacitinib Phase 2
• Diphenhydramine Phase 3
• Diphenhydramine hydrochloride Phase 2
• Efgartigimod alfa Phase 2
• Etanercept Phase 2
• Felzartamab Phase 1

Other linked drugs (2)

• Abetimus
• Tacrolimus